FORA Capital’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Buy
+3,453
New +$145K 0.01% 334
2025
Q3
– Sell
-7,636
Closed -$206K – 680
2025
Q2
$206K Buy
+7,636
New +$221K 0.02% 450
2021
Q1
– Sell
-4,415
Closed -$216K – 1124
2020
Q4
$216K Buy
4,415
+3,440
+353% +$159K 0.03% 503
2020
Q3
$32K Buy
+975
New +$31K 0.02% 515
2020
Q2
– Sell
-2,535
Closed -$62K – 1335
2020
Q1
$62K Buy
+2,535
New +$63.8K 0.01% 719

Other funds holding VCYT

FORA Capital's VCYT Position: Q2 2026 in Review

FORA Capital opened a new position in Veracyte (VCYT) in Q2 2026: 3,453 shares worth $203K. The stake represents 0.01% of the portfolio and ranks #334 among its holdings. This is a return to the name: FORA Capital previously reported a position in VCYT as recently as Q2 2025.

FORA Capital first reported a position in VCYT in Q1 2020 and has held it in 5 quarters since. The position peaked at $216K in Q4 2020. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • FORA Capital held 3,453 shares of Veracyte worth $203K as of Q2 2026.
  • Veracyte was a new FORA Capital position in Q2 2026.
  • Veracyte made up 0.01% of FORA Capital's portfolio in Q2 2026, its #334 holding.
  • FORA Capital first reported a position in Veracyte in Q1 2020 and has held it in 5 quarters since.
  • FORA Capital's Veracyte position peaked at $216K in Q4 2020.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.